Page last updated: 2024-08-25

methyl syringate and Cancer of Lung

methyl syringate has been researched along with Cancer of Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jin, M; Lee, Y; Park, J; Rhyu, MR; Shim, MK1

Other Studies

1 other study(ies) available for methyl syringate and Cancer of Lung

ArticleYear
Methyl syringate, a TRPA1 agonist represses hypoxia-induced cyclooxygenase-2 in lung cancer cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2016, Mar-15, Volume: 23, Issue:3

    Topics: Calcium Channels; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Epithelial Cells; Gallic Acid; Humans; Lung Neoplasms; Neoplasm Invasiveness; Nerve Tissue Proteins; Promoter Regions, Genetic; Transient Receptor Potential Channels; TRPA1 Cation Channel; Vascular Endothelial Growth Factor A

2016